FTC, HHS Seek Public Comment on Generic Drug Shortages and Competition Amongst Powerful Middlemen
Today the Federal Trade Commission (FTC) and the U.S. Department of Health and Human Services (HHS) jointly issued a Request for Information to understand how the practices of two types of pharmaceutical drug middlemen groups—group purchasing organizations (GPOs) and drug wholesalers—may be contributing to generic drug shortages.
Other Articles in this Edition
ADHD-like traits could offer humans an advantage in foraging, study suggests
More Young People Are on Multiple Psychiatric Drugs, Study Finds
Threatened Miscarriage Associated With Increased ASD, ADHD Risk in Children
Childhood Lead Exposure Found to Be Positively Associated With ADHD Diagnosis
Stimulants for ADHD Not Linked to Prescription Drug Misuse
ADHD is somewhat heritable, study finds
Adults with ADHD exhibit camouflaging behavior
Depressive symptoms are a key link between ADHD and hypersexuality, study suggests
FTC, HHS Seek Public Comment on Generic Drug Shortages and Competition Amongst Powerful Middlemen
Why People With ADHD Are So Prone To Black-And-White Thinking